Pete Mariani

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 22% 68% 82%
Transactions
9 44% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer LENSAR Inc July 8, 2014 - Jan. 1, 2015
Pete Mariani's trades of Cytosorbents Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
318.32
Quantity 40,489 -12.3%
Value US$2,280,635
Transaction date
Proposed sale
Price
377.15
Quantity 46,726
Value US$2,541,168
Transaction date
Purchase
Price
285.89
Quantity 63,471 -49.7%
Value US$4,838,898
Transaction date
Purchase
Price
0.89
Quantity 20,000 +5.5%
Value US$17,872
Transaction date
Purchase
Price
0.89
Quantity 11,363 +3.2%
Value US$10,103
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.50
Quantity 7,970 -11.1%
Value US$59,775
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.51
Quantity 3,120 -4.2%
Value US$23,431
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.52
Quantity 1,410 -1.9%
Value US$10,603
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
7.50
Quantity 12,500
Value US$93,810
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
9.36
Quantity 14,550 -19.0%
Value US$136,188
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
9.55
Quantity 14,320 -20.5%
Value US$136,756
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
9.69
Quantity 14,111 -22.4%
Value US$136,736
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
10.16
Quantity 20,940 -33.2%
Value US$212,750
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
9.90
Quantity 20,939 -33.2%
Value US$207,296
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
10.23
Quantity 20,939 -33.2%
Value US$214,206
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
11.88
Quantity 10,649 -26.4%
Value US$126,510
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
17.81
Quantity 1,293 -11.1%
Value US$23,028
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
16.42
Quantity 481 -7.0%
Value US$7,898
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
12.41
Quantity 1,745 -25.9%
Value US$21,662
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
12.41
Quantity 12,854 -65.6%
Value US$159,518
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
12.41
Quantity 1,084 -5.2%
Value US$13,452
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
12.41
Quantity 60,000 -74.4%
Value US$744,720
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-15
B Purchase
40,489 -12.3%
318.32
US$2,280,635 		40,489 -12.3% 318.32 US$2,280,635
2025-08-19 2025-08-19
PrS Proposed sale
46,726
377.15
US$2,541,168 		46,726 377.15 US$2,541,168
2024-12-16 2024-12-13
B Purchase
63,471 -49.7%
285.89
US$4,838,898 		63,471 -49.7% 285.89 US$4,838,898
2024-12-13 2024-12-12
B Purchase
20,000 +5.5%
0.89
US$17,872 		20,000 +5.5% 0.89 US$17,872
2024-12-13 2024-12-11
B Purchase
11,363 +3.2%
0.89
US$10,103 		11,363 +3.2% 0.89 US$10,103
2023-12-13 2023-12-11
US AxoGen, Inc. (AXGN)
S Sale
7,970 -11.1%
7.50
US$59,775 		7,970 -11.1% 7.50 US$59,775
2023-12-13 2023-12-11
US AxoGen, Inc. (AXGN)
S Sale
3,120 -4.2%
7.51
US$23,431 		3,120 -4.2% 7.51 US$23,431
2023-12-13 2023-12-11
US AxoGen, Inc. (AXGN)
S Sale
1,410 -1.9%
7.52
US$10,603 		1,410 -1.9% 7.52 US$10,603
2023-12-11 2023-12-11
US AxoGen, Inc. (AXGN)
PrS Proposed sale
12,500
7.50
US$93,810 		12,500 7.50 US$93,810
2023-02-01 2023-02-01
US AxoGen, Inc. (AXGN)
PlS Planned sale
14,550 -19.0%
9.36
US$136,188 		14,550 -19.0% 9.36 US$136,188
2023-02-01 2023-01-31
US AxoGen, Inc. (AXGN)
PlS Planned sale
14,320 -20.5%
9.55
US$136,756 		14,320 -20.5% 9.55 US$136,756
2023-02-01 2023-01-30
US AxoGen, Inc. (AXGN)
PlS Planned sale
14,111 -22.4%
9.69
US$136,736 		14,111 -22.4% 9.69 US$136,736
2023-01-27 2023-01-27
US AxoGen, Inc. (AXGN)
PlS Planned sale
20,940 -33.2%
10.16
US$212,750 		20,940 -33.2% 10.16 US$212,750
2023-01-27 2023-01-26
US AxoGen, Inc. (AXGN)
PlS Planned sale
20,939 -33.2%
9.90
US$207,296 		20,939 -33.2% 9.90 US$207,296
2023-01-27 2023-01-25
US AxoGen, Inc. (AXGN)
PlS Planned sale
20,939 -33.2%
10.23
US$214,206 		20,939 -33.2% 10.23 US$214,206
2022-11-18 2022-11-16
US AxoGen, Inc. (AXGN)
PlS Planned sale
10,649 -26.4%
11.88
US$126,510 		10,649 -26.4% 11.88 US$126,510
2020-12-30 2020-12-29
US AxoGen, Inc. (AXGN)
S Sale
1,293 -11.1%
17.81
US$23,028 		1,293 -11.1% 17.81 US$23,028
2020-12-22 2020-12-21
US AxoGen, Inc. (AXGN)
S Sale
481 -7.0%
16.42
US$7,898 		481 -7.0% 16.42 US$7,898
2020-11-03 2020-10-30
US AxoGen, Inc. (AXGN)
PlS Planned sale
1,745 -25.9%
12.41
US$21,662 		1,745 -25.9% 12.41 US$21,662
2020-11-03 2020-10-30
US AxoGen, Inc. (AXGN)
PlS Planned sale
12,854 -65.6%
12.41
US$159,518 		12,854 -65.6% 12.41 US$159,518
2020-11-03 2020-10-30
US AxoGen, Inc. (AXGN)
PlS Planned sale
1,084 -5.2%
12.41
US$13,452 		1,084 -5.2% 12.41 US$13,452
2020-11-03 2020-10-30
US AxoGen, Inc. (AXGN)
PlS Planned sale
60,000 -74.4%
12.41
US$744,720 		60,000 -74.4% 12.41 US$744,720